COMP <GO>
MMM vs JNJ // ENTERPRISE SCALE & MARKET CAP
3M Company (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: MMM 4
— JNJ 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $174.34 (-1.70%) • MKT CAP: $91.65B
market-cap
$91.65B
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMM VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMM | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.90% | 67.90% | -28.00 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 32.90% | 25.50% | +7.40 | MMM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.1x | 18.5x | -0.40 | MMM | /valuation <GO> |
| Free Cash Flow Yield | 1.52% | 2.97% | -1.45 | JNJ | /fcf-yield <GO> |
| Operating Margin | 18.60% | 34.70% | -16.10 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 13.00% | 28.50% | -15.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 6.00% | -4.50 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.70% | 0.00% | +1.70 | MMM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.37 | 5.59 | -1.22 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.20% | -0.60 | MMM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 60.4 | -1.83 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.08 | -0.17 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.2x | 23.0x | +3.20 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $91.65B | $662.49B | -$570.84B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMM REV | JNJ REV | MMM GROSS % | JNJ GROSS % | MMM FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.95B | $94.19B | 39.9% | 67.9% | $1.40B | $19.70B |
| FY 2024 | $24.57B | $88.82B | 41.2% | 69.1% | $638.0M | $19.84B |
| FY 2023 | $24.61B | $85.16B | 44.0% | 44.0% | $5.57B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMM // BETA 0.91
JNJ // BETA 1.08